Mr. John Fair joined Daré Bioscience, Inc. in 2018 and currently serves as Chief Strategy Officer where he is responsible for licensing, acquisitions, strategic partnering and corporate strategy. Mr. Fair was previously Managing Director of Capital F Consulting, a privately held consulting firm focused on healthcare consulting, capital raising and investor communications. From January 2015 to September 2016, Mr. Fair was President and COO of Evofem, then a privately held specialty healthcare company developing products for women’s health, microbiome and infectious disease. In that role, Mr. Fair was responsible for commercial strategy, operations and product development. He successfully initiated several new programs targeting bacterial and virologic diseases and microbiome disorders. From December 2012 to December 2014, Mr. Fair held senior level roles at Evofem, and its global product distribution partner, WCG. Previously, Mr. Fair served in a number of executive level roles for specialty healthcare and venture-backed healthcare service businesses and was instrumental in building companies and capabilities that led to successful M&A exits. Mr. Fair has broad therapeutic experience that includes oncology, hematology, virology and women’s health. Mr. Fair began his career as a portfolio strategy and insights consultant and supported numerous brands and franchises in the pharmaceutical, OTC and consumer healthcare markets. Mr. Fair holds a master’s degree from the University of Pennsylvania, Perelman School of Medicine and a bachelor’s degree from Rider University. He has completed executive education in corporate strategy, mergers and acquisitions at Stanford University Graduate School of Business.